vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $32.2M, roughly 1.3× OptimizeRx Corp). OptimizeRx Corp runs the higher net margin — 15.6% vs -17.9%, a 33.5% gap on every dollar of revenue. On growth, OptimizeRx Corp posted the faster year-over-year revenue change (-0.2% vs -23.2%). OptimizeRx Corp produced more free cash flow last quarter ($7.1M vs $-10.8M). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs -27.2%).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CMBM vs OPRX — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.3× larger
CMBM
$40.3M
$32.2M
OPRX
Growing faster (revenue YoY)
OPRX
OPRX
+22.9% gap
OPRX
-0.2%
-23.2%
CMBM
Higher net margin
OPRX
OPRX
33.5% more per $
OPRX
15.6%
-17.9%
CMBM
More free cash flow
OPRX
OPRX
$17.9M more FCF
OPRX
$7.1M
$-10.8M
CMBM
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
-27.2%
CMBM

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CMBM
CMBM
OPRX
OPRX
Revenue
$40.3M
$32.2M
Net Profit
$-7.2M
$5.0M
Gross Margin
36.6%
74.8%
Operating Margin
-28.4%
26.6%
Net Margin
-17.9%
15.6%
Revenue YoY
-23.2%
-0.2%
Net Profit YoY
71.0%
6535.9%
EPS (diluted)
$-0.26
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
OPRX
OPRX
Q4 25
$32.2M
Q3 25
$26.1M
Q2 25
$29.2M
Q1 25
$21.9M
Q4 24
$40.3M
$32.3M
Q3 24
$44.7M
$21.3M
Q2 24
$45.2M
$18.8M
Q1 24
$47.1M
$19.7M
Net Profit
CMBM
CMBM
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$779.0K
Q2 25
$1.5M
Q1 25
$-2.2M
Q4 24
$-7.2M
$-78.0K
Q3 24
$-34.5M
$-9.1M
Q2 24
$-14.2M
$-4.0M
Q1 24
$-18.4M
$-6.9M
Gross Margin
CMBM
CMBM
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
36.6%
68.1%
Q3 24
43.6%
63.1%
Q2 24
32.5%
62.2%
Q1 24
29.8%
62.0%
Operating Margin
CMBM
CMBM
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
-28.4%
11.2%
Q3 24
-69.6%
-40.2%
Q2 24
-27.2%
-19.9%
Q1 24
-33.1%
-25.5%
Net Margin
CMBM
CMBM
OPRX
OPRX
Q4 25
15.6%
Q3 25
3.0%
Q2 25
5.2%
Q1 25
-10.0%
Q4 24
-17.9%
-0.2%
Q3 24
-77.3%
-42.8%
Q2 24
-31.5%
-21.3%
Q1 24
-39.2%
-35.0%
EPS (diluted)
CMBM
CMBM
OPRX
OPRX
Q4 25
$0.27
Q3 25
$0.04
Q2 25
$0.08
Q1 25
$-0.12
Q4 24
$-0.26
$0.00
Q3 24
$-1.22
$-0.50
Q2 24
$-0.51
$-0.22
Q1 24
$-0.66
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
$67.6M
$26.3M
Stockholders' EquityBook value
$-3.2M
$128.3M
Total Assets
$173.7M
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$16.6M
Q1 25
$16.6M
Q4 24
$13.4M
Q3 24
$16.1M
Q2 24
Q1 24
Total Debt
CMBM
CMBM
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$67.6M
$34.3M
Q3 24
$67.6M
$36.8M
Q2 24
$68.9M
$37.3M
Q1 24
$63.8M
$37.8M
Stockholders' Equity
CMBM
CMBM
OPRX
OPRX
Q4 25
$128.3M
Q3 25
$122.3M
Q2 25
$119.3M
Q1 25
$116.3M
Q4 24
$-3.2M
$117.0M
Q3 24
$1.9M
$114.5M
Q2 24
$34.1M
$121.0M
Q1 24
$45.0M
$122.5M
Total Assets
CMBM
CMBM
OPRX
OPRX
Q4 25
$176.9M
Q3 25
$170.3M
Q2 25
$169.3M
Q1 25
$167.8M
Q4 24
$173.7M
$171.2M
Q3 24
$194.3M
$165.2M
Q2 24
$221.1M
$172.9M
Q1 24
$219.8M
$176.4M
Debt / Equity
CMBM
CMBM
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
36.12×
0.32×
Q2 24
2.02×
0.31×
Q1 24
1.42×
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
OPRX
OPRX
Operating Cash FlowLast quarter
$-10.4M
$7.1M
Free Cash FlowOCF − Capex
$-10.8M
$7.1M
FCF MarginFCF / Revenue
-26.8%
22.0%
Capex IntensityCapex / Revenue
1.1%
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$-21.4M
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.9M
Q4 24
$-10.4M
$198.0K
Q3 24
$8.9M
$1.8M
Q2 24
$2.4M
$782.0K
Q1 24
$-15.9M
$2.1M
Free Cash Flow
CMBM
CMBM
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$-10.8M
$181.0K
Q3 24
$6.8M
$1.8M
Q2 24
$87.0K
$737.0K
Q1 24
$-17.4M
$2.1M
FCF Margin
CMBM
CMBM
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
-26.8%
0.6%
Q3 24
15.2%
8.3%
Q2 24
0.2%
3.9%
Q1 24
-37.0%
10.6%
Capex Intensity
CMBM
CMBM
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
1.1%
0.1%
Q3 24
4.8%
0.1%
Q2 24
5.1%
0.2%
Q1 24
3.3%
0.2%
Cash Conversion
CMBM
CMBM
OPRX
OPRX
Q4 25
1.41×
Q3 25
4.11×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

OPRX
OPRX

Segment breakdown not available.

Related Comparisons